Saba Capital Management, L.P. bought HQL
April 18, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 81,738 shares of Abrdn Life Sciences Investors at $12.80 per share, a transaction worth $1.05M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
81,738
Price
$12.80
Total value
$1.05M
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 18, 2024
Filing dateApril 22, 2024
Shares owned after2,694,511
OwnershipIndirect
10b5-1 planNo
AmendedNo